Understanding how PUM1 mutations affect neurological diseases
Deciphering the Role of the Pumilio1 in Two Distinct Neurological Diseases
This study is looking at how a protein called PUM1 affects different neurological conditions caused by various mutations, using mice and human patients to understand why some people have mild symptoms while others have more severe issues, with the hope of finding new treatment options for those affected.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11075360 on NIH RePORTER |
What this research studies
This research investigates the role of the PUM1 protein in two distinct neurological conditions that arise from different mutations. By studying mice models and human patients, the researchers aim to uncover how these mutations lead to varying symptoms, such as mild ataxia or severe neurodevelopmental disorders. The approach includes examining the binding of PUM1 to specific RNA regions and its impact on protein levels associated with these diseases. This work could provide insights into potential therapeutic targets for affected individuals.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with identified PUM1 mutations or those exhibiting symptoms related to ataxia or neurodevelopmental syndromes.
Not a fit: Patients without PUM1 mutations or those not exhibiting symptoms related to the studied neurological conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment options for patients with PUM1-related neurological disorders.
How similar studies have performed: Previous research has shown promising results in understanding the role of RNA-binding proteins in neurological diseases, indicating that this approach may yield valuable insights.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Gennarino, Vincenzo Alessandro — Columbia University Health Sciences
- Study coordinator: Gennarino, Vincenzo Alessandro
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.